Home › Hyperuricemia › Massachusetts
Hyperuricemia clinical trials in Massachusetts
3 studies for Hyperuricemia are looking for participants at sites in Massachusetts.
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
- MedVadis Research, Waltham
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 28, 2026 · NCT07089888A Study of Dotinurad Versus Allopurinol in Participants With Gout
- MedVadis Research, Waltham
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 28, 2026 · NCT07089875SAVE-Care (Sodium Glucose Cotransporter-2 Inhibitors [SGLT2i] As Novel Gout Care) Trial
- Massachusetts General Hospital, Boston
RecruitingPhase 4
Ages 18 to 80 · All sexes · Updated Aug 5, 2026 · NCT06674109From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.